AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Conference Call February 15, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Investor Relations Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants Robbie Marcus - JP Morgan Simon Negin - UBS Matthew O’Brien - Piper Sandler Sam Eiber - BTIG Joseph Conway - Needham Daniel Stauder - JMP Suraj Kalia - Oppenheimer & Company Operator Good afternoon, and welcome to AtriCure’s ...

AtriCure (ATRC) reported $106.54 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 21%. EPS of -$0.21 for the same period compares to -$0.09 a year ago.The reported revenue represents a surprise of +0.04% over the Zacks Consensus Estimate of $106.5 million. With the consensus EPS estimate being -$0.22, the EPS surprise was +4.55%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Str ...

AtriCure (ATRC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.55%. A quarter ago, it was expected that this medical device maker would post a loss of $0.30 per share when it actually produced a loss of $0.20, delivering a surprise of 33.33%.Over the last four quarters, the company has sur ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________ FORM 10-K _________________________________ ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51470 ____________________________________ AtriCure, Inc. (Exact name of registrant as specified in i ...

AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Marissa Bych – Gilmartin Group, Investor Relations Mike Carrel – President and Chief Executive Officer Angie Wirick – Chief Financial Officer Conference Call Participants Robbie Marcus – J.P. Morgan Danielle Antalffy – UBS Mike Matson – Needham and Company Sam Eiber – BTIG Suraj Kalia – Oppenheimer & Co Operator Good afternoon, and welcome to AtriCure’s Third Quarter 2023 Earnings Conference Call. ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.001 par value ATRC NASDAQ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _____________________________________________ FORM 10-Q ___________________________________________________________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ¨ TRANSITIO ...

AtriCure, Inc. (NASDAQ:ATRC) Q2 2023 Earnings Conference Call July 25, 2023 4:30 PM ET Company Participants Marissa Bych - Vice President-Gilmartin Group Mike Carrel - President & CEO Angie Wirick - CFO Conference Call Participants Robert Marcus - J.P. Morgan William Plovanic - Canaccord Matthew O’Brien - Piper Sandler Marie Thibault - BTIG Frederick Wise - Stifel Michael Matson - Needham Suraj Kalia - Oppenheimer Operator Good afternoon, and welcome to AtriCure's Second Quarter 2023 Earnings Conference Cal ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.001 par value ATRC NASDAQ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _____________________________________________ FORM 10-Q ___________________________________________________________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ¨ TRANSITION REP ...

AtriCure, Inc. (NASDAQ:ATRC) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Marissa Bych – Vice President-Gilmartin Group Mike Carrel – President and Chief Executive Officer Angie Wirick – Chief Financial Officer Conference Call Participants Matthew O’Brien – Piper Sandler Marie Thibault – BTIG John McAulay – Stifel Joseph Conway – Needham Suraj Kalia – Oppenheimer Operator Good afternoon, and welcome to AtriCure's First Quarter 2023 Earnings Conference Call. At this time, all ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _____________________________________________ FORM 10-Q ___________________________________________________________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____________to_ ...